FDA approves new updated COVID-19 vaccines to target KP.2 variant. Here’s what to know
Fast CompanyThe Food and Drug Administration (FDA) has approved new formulations of COVID-19 vaccines from Moderna and Pfizer-BioNTech. These updated vaccines are specifically tailored to target the KP.2 strain, a descendant of the JN.1 variant, which i…